Avadel Pharmaceuticals (AVDL) Free Cash Flow: 2014-2022
Historic Free Cash Flow for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to -$15.4 million.
- Avadel Pharmaceuticals' Free Cash Flow rose 31.72% to -$15.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$71.0 million, marking a year-over-year increase of 8.17%. This contributed to the annual value of -$46.9 million for FY2024, which is 63.50% up from last year.
- As of Q4 2022, Avadel Pharmaceuticals' Free Cash Flow stood at -$15.4 million, which was down 104.36% from -$7.5 million recorded in Q3 2022.
- Over the past 5 years, Avadel Pharmaceuticals' Free Cash Flow peaked at -$1.4 million during Q2 2019, and registered a low of -$34.0 million during Q1 2022.
- In the last 3 years, Avadel Pharmaceuticals' Free Cash Flow had a median value of -$14.7 million in 2022 and averaged -$16.4 million.
- In the last 5 years, Avadel Pharmaceuticals' Free Cash Flow crashed by 521.28% in 2018 and then surged by 92.77% in 2019.
- Over the past 5 years, Avadel Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$24.5 million in 2018, then soared by 66.37% to -$8.3 million in 2019, then slumped by 132.52% to -$19.2 million in 2020, then fell by 17.28% to -$22.5 million in 2021, then spiked by 31.72% to -$15.4 million in 2022.
- Its Free Cash Flow was -$15.4 million in Q4 2022, compared to -$7.5 million in Q3 2022 and -$14.1 million in Q2 2022.